Holen Sie sich die Stockscreener-App
41.53
1.79%
0.73
Vorhandelsmarkt:
41.55
0.02
+0.05%
Omnicell Inc Aktie (OMCL) Neueste Nachrichten
How The Titan XT Cycle Is Rewriting The Omnicell (OMCL) Investment Story - Yahoo Finance
Will Strong Q4 Beat and Software Pivot Change Omnicell's (OMCL) Investment Narrative? - Yahoo Finance
Omnicell, Inc. $OMCL Shares Sold by JPMorgan Chase & Co. - MarketBeat
Omnicell Stock Analysis: Strong Performance vs. Long-Term ConcernsNews and Statistics - IndexBox
OMCL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Omnicell, Inc. (OMCL) Stock Analysis: Strong Buy Ratings And Nearly 40% Upside Potential - DirectorsTalk Interviews
Vanguard Group Inc. Has $170.89 Million Holdings in Omnicell, Inc. $OMCL - MarketBeat
Roubaix Capital LLC Purchases Shares of 76,383 Omnicell, Inc. $OMCL - MarketBeat
3 Reasons to Avoid OMCL and 1 Stock to Buy Instead - Finviz
What is Zacks Research's Estimate for Omnicell Q1 Earnings? - MarketBeat
Dividend Watch: Whats the fair value of Omnicell Inc stockEarnings Overview Summary & Verified Momentum Stock Watchlist - baoquankhu1.vn
Omnicell, Inc. (OMCL): A Bull Case Theory - Insider Monkey
Should Omnicell’s Shift Toward Software and Services Require Action From Omnicell (OMCL) Investors? - Sahm
OMCL Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
What is Zacks Research's Estimate for Omnicell Q3 Earnings? - MarketBeat
Omnicell, Inc. (NASDAQ:OMCL) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Decoding Omnicell Inc (OMCL): A Strategic SWOT Insight - GuruFocus
(OMCL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Omnicell, Inc. (OMCL) Investor Outlook: Examining a 45% Potential Upside Amid Healthcare Innovation - DirectorsTalk Interviews
Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know - Finviz
Healthcare Inventory Management Market Hits New High | Major - openPR.com
Omnicell Inc (OMCL) Trading 3.26% Higher on Feb 20 - GuruFocus
Omnicell (OMCL) VP reports tax withholding and ESPP share purchase - Stock Titan
Omnicell (OMCL) insider plans Rule 144 sale of 4,243 vested shares - Stock Titan
Hospital Robotics (Logistics and Pharmacy) Market to Reach USD - openPR.com
Does Omnicell’s Profit Squeeze Amid Higher Sales and 2026 Outlook Change The Bull Case For OMCL? - simplywall.st
Merger Talk: Is NewAmsterdam Pharma Company NVs ROIC above industry average2025 Technical Overview & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
Omnicell, Inc. (NASDAQ:OMCL) Sees Large Drop in Short Interest - MarketBeat
Responsive Playbooks and the OMCL Inflection - Stock Traders Daily
Growth Report: How volatile is Omnicell Inc stock2025 Price Momentum & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Reasons to add Omnicell stock to your portfolio right now - MSN
Smart Medicine Compounding Robot Market Is Going to Boom | ARxIUM - openPR.com
Omnicell (OMCL) Is Down 19.0% After Profit Squeeze Despite Solid 2026 Revenue OutlookWhat's Changed - Yahoo Finance
Little Excitement Around Omnicell, Inc.'s (NASDAQ:OMCL) Revenues As Shares Take 26% Pounding - 富途牛牛
Why Investors Shouldn't Be Surprised By Omnicell, Inc.'s (NASDAQ:OMCL) 26% Share Price Plunge - simplywall.st
The Top 5 Analyst Questions From Omnicell's Q4 Earnings Call - Finviz
The Top 5 Analyst Questions From Omnicell’s Q4 Earnings Call - Yahoo Finance
Omnicell (NASDAQ:OMCL) Cut to Strong Sell at Zacks Research - MarketBeat
Omnicell, Inc. (OMCL) Stock Analysis: Unpacking a Potential 57% Upside in Healthcare Automation - DirectorsTalk Interviews
Omnicell (OMCL) Q4 2025 Earnings Call Transcript - AOL.com
Omnicell: Solid Execution and Strategic Promise Offset by Near-Term Profitability Pressures and Premium Valuation (Hold Rating Maintained) - TipRanks
Omnicell, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:OMCL) 2026-02-08 - Seeking Alpha
Omnicell upgraded at BofA on buying opportunity ahead of Q4 results - MSN
Omnicell (OMCL) Margin Squeeze To 0.2% Net Profit Tests Bullish Recovery Narratives - Sahm
Analysts Conflicted on These Healthcare Names: Cigna (CI), Hims & Hers Health (HIMS) and Omnicell (OMCL) - The Globe and Mail
Omnicell (NASDAQ:OMCL) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat
Omnicell Earnings Call: Growth Intact, Margins Under Strain - The Globe and Mail
Omnicell, Inc. (NASDAQ:OMCL) Q4 2025 Earnings Call Transcript - Insider Monkey
Omnicell (NASDAQ:OMCL) Stock Price Down 4.2% on Disappointing Earnings - MarketBeat
Analyst Jessica Tassan Lowers Omnicell (OMCL) Price Target to $4 - GuruFocus
Omnicell Q4 2025 Earnings: Stock Dives on Missed EPS, 2026 GuidanceNews and Statistics - IndexBox
Omnicell Stock Pre-Market (-15%) : Q4 EPS Miss & Weak 2026 Guidance - Trefis
Pharmacy Automation Systems Market Set for Explosive Growth - openPR.com
OMCL Q4 Deep Dive: Product Launches, Tariff Headwinds, and Margin Pressures Shape Outlook - Finviz
Omnicell Stock Pre-Market (+15%): Raises FY26 Guidance on Strong Titan XT Adoption - Trefis
Omnicell Q4 Earnings Call Highlights - MarketBeat
Omnicell targets $1.215B–$1.255B 2026 revenue as Titan XT and OmniSphere fuel platform push - MSN
Omnicell Q4 2025 slides: EPS miss drives 15% stock drop despite revenue growth - Investing.com Nigeria
Omnicell Inc (OMCL) Q4 2025 Earnings Call Highlights: Strong Dem - GuruFocus
0.25%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):